Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analatro for Black Widow Spider Bites
NCT00657540Phase 3Completed
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Start
- Oct 2009
- Primary completion
- Oct 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Antivenin (Latrodectus mactans) in latrodectism, sponsored by Instituto Bioclon S.A. de C.V.. Started Oct 2009; status: completed.
02
Drugs
Antivenin (Latrodectus mactans)
03
Conditions
latrodectism
Beyond the preview
Go deeper on NCT00657540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657540.